Evidence map›Paper›PMID 26199937›Full record

ArticleBioMed research international2015

Gold Nanoparticles Promote Oxidant-Mediated Activation of NF-κB and 53BP1 Recruitment-Based Adaptive Response in Human Astrocytes.

Jennifer Mytych, Anna Lewinska, Jacek Zebrowski, Maciej Wnuk

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Convenient Synthesis ofACS omega · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Synthesis of MnNanomaterials (Basel, Switzerland) · 2019
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jennifer MytychDepartment of Genetics, University of Rzeszow, Rejtana 16C, 35-959 Rzeszow, Poland.
Anna LewinskaDepartment of Biochemistry and Cell Biology, University of Rzeszow, Zelwerowicza 4, 35-601 Rzeszow, Poland.
Jacek ZebrowskiDepartment of Plant Physiology, University of Rzeszow, Werynia 502, 36-100 Kolbuszowa, Poland.
Maciej WnukDepartment of Genetics, University of Rzeszow, Rejtana 16C, 35-959 Rzeszow, Poland.
Rzeszów University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanogold-based materials are promising candidate tools for nanobased medicine. Nevertheless, no conclusive information on their cytotoxicity is available. In the present study, we investigated the effects of gold nanoparticles (AuNPs) on human astrocytes in vitro. Nanogold treatment in a wide range of concentrations did not result in cytotoxicity. In contrast, nanogold provoked changes in the astrocyte cell cycle and induced senescence-associated β-galactosidase activity. AuNPs promoted oxidative stress and caused activation of NF-κB pathway. After nanogold treatment, an inverse correlation between the formation of 53BP1 foci and micronuclei generation was observed. The robust 53BP1 recruitment resulted in reduced micronuclei production. Thus, nanogold treatment stimulated an adaptive response in a human astrocyte cell.

Indexed as

AstrocytesCell LineGoldHumansIntracellular Signaling Peptides and ProteinsMetal NanoparticlesMicronuclei, Chromosome-DefectiveNanomedicineNF-kappa BTumor Suppressor p53-Binding Protein 1GoldIntracellular Signaling Peptides and ProteinsNF-kappa BTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID26199937
PMCPMC4493286
OpenAlexW1507477242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.